• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Donations for a trial using BC 007 specifically for me/cfs

Alvin2

The good news is patients don't die the bad news..
Messages
3,024
Should start a separate fundraiser for that?
It already happens twice a year.

I am dismayed that people would donate so much money for a very highly overpriced pie in the sky idea thats little better than buying lottery tickets instead of reporting that would help decimate the psychosomatic claptrap and could lead to real ME/CFS research funding.
 
Messages
600
BC007 takes out certains specific autoantibodies (the immune system attacking receptors in the body).

The whole point of BC007 is to take out these antibodies without affecting other antibodies.

That means, if Rituximab didn't work, BC007 can't possibly work. But if it does, it doesn't wipe out the rest of the immune system, like Rituximab does.

There is little point in raising 800 000 USD for this trial, as the major hurdle is selecting patients, not removing the antibodies, which can simply be done with Rituximab or even cheap steroids. Why don't we use steroids for
[...]
I dont think rituximab wipes out the immune system. Antibodies are produced by plasma cells and plasmablasts, rituximab can only wipe out some of the latter ones since they still express some cd20. Plasma cells can live for years+ so if this is the source of the autoantibodies you cant touch them with rituximab.
 
Last edited:
Messages
92
1644513018754.png
 

Husband of

Senior Member
Messages
318
I think it only targets certain antibodies, namely the GPCR autoantibodies, specifically the beta-1 adrenergic and the alpha-1 adrenergic receptor. Here is a quote on this from another thread:

https://forums.phoenixrising.me/thr...ases-applicable-to-me-cfs.84695/#post-2352589


My question is, it seems that only a subset of ME/CFS patients are positive for these autoantibodies (https://pubmed.ncbi.nlm.nih.gov/26399744/), does this mean this medication would only be helpful for those individuals?
Can one test for these antibodies?
 

Shanti1

Administrator
Messages
3,188
Can one test for these antibodies?
Yes, CellTrend in Germany tests for them: https://www.celltrend.de/en/pots-cfs-me-sfn/important-publications/

I'm not sure where you are in the world, but I had my blood sent 2nd day via fed-ex from the US to have the testing done. The POTS/Long-COVID is the panel you would want. I also did the SFN panel. I did not have any antibodies show up as positive, but many people do.

There is debate on how closely the antibodies correlate with with ME/CFS and POTs as some percentage of healthy individuals has them as well. This thread has a nice discussion:
https://forums.phoenixrising.me/threads/relevance-of-celltrend-results-for-treatment.87644/

Nonetheless, I think it is helpful when trying to figure out if someone may be a candidate for BC007 and other antibody depleting/modulating therapies such as immunoadsorption, IV IgG, or B-cell depletion.